How I treat Logo
howitreat.in

A user-friendly, frequently updated reference guide that aligns with international guidelines and protocols.

Functional Abnormalities of Neutrophils

Indications for evaluation of neutrophil function

  • Severe systemic infections in children. Ex: sepsis, osteomyelitis, meningitis
  • Infections at unusual sites. Ex: hepatic or brain abscess
  • Recurrent bacterial infections- Ex: pneumonia, sinusitis, lymphadenitis, otitis media
  • Infections with unusual pathogens- Ex: Aspergillus pneumonia, disseminated candidiasis, Serratia marcescens, nocardia species, burkholderia cepacia
  • Chronic gingivitis/ recurrent aphthous ulcers

 

Defective adhesion 

  • Leucocyte adhesion deficiency
    • Autosomal recessive inheritance
    • Subtypes
      • Type 1- Deficiency of beta 2 integrins and CD11/CD18 complex. 
      • Type 2- Lack of fucosylation of ligands for selectins
      • Type 3- Mutation of FERMT3 which encodes kindlin-3 on hematopoietic cells. Normally this protein binds to beta integrin
    • Defects are seen in adhesion related functions such as
      • Adhesion to endothelial cells
      • C3b/ Opsonin mediated phagocytosis
      • Particle triggered respiratory burst activation
      • Degranulation
    •  Clinical features
      • Patient has increased risk of infections with marked leucocytosis, without pus formation at infection site.
      • Severe and progressive generalized periodontitis
    • Investigations
      • Flow cytometry- To look for expression of CD11b and CD15 (Selectin) on neutrophils
      • Hemogram- Neutrophilia
        • Baseline—15,000- 60,000/cmm
        • During infections- >1,00,000/cmm
      • Bone marrow aspiration- Granulocytic hyperplasia
    • Treatment
      • Prophylactic antibiotics and cotrimoxazole
      • Maintain oral hygiene
      •  Bone marrow transplantation in severe cases
  • Drug induced

 

Defective locomotion and chemotaxis

  • Neonatal neutrophils
  • Actin polymerization abnormalities
    • Recurrent pyogenic infections
    • Autosomal recessive
    • Generally lethal
    • Treatment- HSCT
  • IL-2 administration
  • Cardiopulmonary bypass
  • Drugs- Ethanol, glucocorticoids

 

Defective microbial killing

  • Chronic granulomatous disease
    • X Linked and autosomal recessive inheritance
    • 2/3rd of cases have mutation of CYBB gene, which encodes gp91phox component of the membrane cytochrome b protein complex
    • Defect – Lack of respiratory burst and super oxide production due to defect in NADPH oxidase
    • Neutrophils ingest but do not kill catalase positive organism
    • Morphology of neutrophils is normal
    • Clinical features
      • Recurrent infection with low grade pathogens such as Serratia marcescens, enterobacteraceae, staphylococci
      • Recurrent pneumonia, osteomyelitis, lymphadenitis, hepatic abscess 
    • Morphology - Granulomas are seen in affected tissues.
    • Investigations  
      • Nitro blue tetrazolium dye test. 
        • NBT (Yellow dye) + Neutrophils + Micro organism 
        • Normal –Increased leukocytic production of H2O2 and O which reduce Yellow NBT to formazan, a blue compound
      • Flow cytometry using dihydrorhodamine-123 fluorescence
        • If H2O2 is present, there is oxidation of dihydrorhodamine-123 to Rhodamine 123 which has fluorescence.
        • Gives absolute number of cells affected and also degree of deficiency
      • PCR to identify the genetic defect. This can be used for prenatal diagnosis.
    • Treatment - 
      • Prophylactic antibiotics, cotrimoxazole, itraconazole
      • All routine vaccinations including live viral vaccines can be given.
      • Rec. INF- Gamma- 50mcg/m2- 3 times a week- Enhances phagocytic function and killing by non-oxidative mechanisms.
      • Surgical drainage if needed
      • HSCT- 
        • Only option of cure
        • Should be done if there are recurrent infections despite of aggressive medical treatment and there is a matched sibling donor
      • Gene therapy- It is being tried on experimental basis
  • RAC-2 deficiency
    • Autosomal dominant
    • Dominant negative inhibition by mutant protein of Rac-2 mediated function. Failure of membrane receptor mediated O2 generation and chemotaxis.
    • Present with recurrent infections and neutrophilia
  • Myeloperoxidase deficiency
    • Autosomal recessive  
    • MPO gene is located on chromosome 17.
    • 4 mutations have been identified.
    • It is a benign disorder in which infection is not a frequent complication
    • MPO stain is negative
    • Acquired forms- Acute myeloid leukemia, MDS, CML, Batten disease, lead intoxication, ceroid lipofuscinosis
  • Hyper IgE syndrome- Discussed in primary immunodeficiency section.
  • Neutrophil G6PD deficiency
  • Glycogen storage disease Ib
  • Extensive burns
  • Ethanol toxicity
  • End stage renal disease
  • Diabetes mellitus

 

Abnormal structure of nucleus or organelle

  • Hereditarymacropolycytes
  • Specific granule deficiency
    • Autosomal recessive
    • Functional loss of myeloid transcription factor (Gff-1 or C/EBPE) which regulates specific granule formation.
    • There is absence of intracellular pool of leucocyte adhesion molecules
    • Reduced defensins, gelatinase, collagenase, vitamin B12 binding protein, and lactoferrin
    • Eosinophils also lack granules
    • There is impaired chemotaxis and bacterial activity
    • Peripheral smear- No specific granules but contain azurophilic granules in neutrophils. Bilobed nuclei in neutrophils.
    • Presents with deep seated abscesses
    • Common pathogens include S. Aureus, Ps. Aerogenosa
    • Treatment- Antibiotics
  • Alder Reilly anomaly
    • Autosomal recessive
    • Defect – Incomplete break down of mucopolysaccharides due to various enzyme deficiencies.
    • Peripheral smear   
      • Leukocytes
      • Large purplish organelles in the cytoplasm
      • They stain metachromatically with toluidine blue
      • Gasser’s cells – Inclusions in lymphocytes tend to occur in clusters in the shape of dots or commas and are surrounded by vacuoles. (They are also seen in Hurler’s & Hunter’s disease)
  • May Hegglin anomaly
    • Autosomal dominant
    • Peripheral smear
      • Granulocytes have large basophilic and pyroninophilic inclusions. They consist of RNA.
      • Giant platelets containing few granules.
  • Chediak Higashi disease
    • Autosomal recessive
    • Defect in CHSI/LYST gene- located on chromosome 1. It encodes a protein involved in regulation of granule fusion.
      • Abnormal fusion of cytoplasmic membranes
      • Impaired locomotion.
      • Decreased cell activity in tissues.
      • Defective chemotaxis due to defect at membrane receptor level.
    • Clinical features  
      • Recurrent pyogenic infections invloving mucus membrane, skin and respiratory tract          
      • Skin hypopigmentation and Silvery hair - Due to failure to disperse melanocytes
      • Lymphadenopathy 
      • Hepatosplenomegaly- Usually due to associated HLH
      • Development of HLH is known as accelerated phase
      • Bleeding time- Prolonged due to platelet storage pool defect
      • Neurological symptoms- Peripheral and cranial neuropathies, autonomic dysfunction, weakness, sensory defect, ataxia
    • Investigations:
      • Peripheral smear: Leukocytes (Neutrophil, lymphocytes and monocytes)
        • Giant gray green peroxides positive bodies in cytoplasm.
        • Formed by aggregation & fusion of primary azurophilic & specific granules
      • Hemogram- Neutropenia- Due to death of myeloid precursors within the bone marrow
      • Bone marrow examination- Normal to hypercellular
      • Flow cytometry- Reduced expression of CD11b/CD18 due to altered membrane fluidity
      • Microscopy of hair shaft- Large speckled pigment clumps as opposed to normal pattern of finally divided pigment of melanin spread along the length of the shaft.
    • Differential diagnosis (Partial albinism with exagerrated bleeding and recurrent infections)
      • Griscelli syndrome
      • Hermansky- Pudlak syndrome
    • Treatment
      • High dose ascorbic acid
        • Infants- 200mg/day
        • Adults- 6gm/day
      • Prophylactic antibiotics
      • HSCT- Potential curative therapy

 

Familial Mediterranean fever 

  • It is a type of autoinflammatory disease (Periodic fever syndrome)
  • First presentation is seen in childhood
  • Presents with sporadic paroxysmal attacks of fever, serosal inflammation (such as peritonitis) and neutrophilia
  • Spontaneous resolution is seen after 1-3 days
  • Autosomal recessive disorder
  • Mutation of MEFV gene, which codes for pyrin protein
  • There is neutrophil overactivity and tissue infiltration
  • Because of chronic inflammation, these patient often have amyloid A amyloidosis.
  • Treatment-
    • Colchicine
    • Severe refractory disease- HSCT
  • Other autoinflammatory diseases include
    • Hyper-IgD syndrome- Mevalonate kinase deficiency
    • TNF receptor associated periodic syndrome
    • Cryopyrin associated periodic syndrome
    • PAPA syndrome- Pyeogenic arthritis, pyederma gangrenosum, and acne
    • PAMI syndrome- PSTPIP1 associated myeloid related proteinemia inflammatory syndrome
    • Majeed syndrome- Sterile, chronic recurrent multifocal osteomyelitis with pain and swelling around the joints, recurrent febrile episodes and congenital dyserythropoietic anemia

 

Howitreat.in

Wish to Reach Hematologists?

Advertise with Us!

Know More

Howitreat.in

Wish to Reach Hematologists?

Advertise with Us!

Know More

Home

About Us

Support Us

An Initiative of

Veenadhare Edutech Private Limited

1299, 2nd Floor, Shanta Nivas,

Beside Hotel Swan Inn, Off J.M.Road, Shivajinagar

Pune - 411005

Maharashtra – India

How I treat Logo
howitreat.in

CIN: U85190PN2022PTC210569

Email: admin@howitreat.in

Disclaimer: Information provided on this website is only for medical education purposes and not intended as medical advice. Although authors have made every effort to provide up-to-date information, the recommendations should not be considered standard of care. Responsibility for patient care resides with the doctors on the basis of their professional license, experience, and knowledge of the individual patient. For full prescribing information, including indications, contraindications, warnings, precautions, and adverse effects, please refer to the approved product label. Neither the authors nor publisher shall be liable or responsible for any loss or adverse effects allegedly arising from any information or suggestion on this website. This website is written for use of healthcare professionals only; hence person other than healthcare workers is advised to refrain from reading the content of this website.